Secondary Hyperparathyroidism in All the Stages of Chronic Kidney Disease in Southern Indian Population
نویسنده
چکیده
Objectives: 1.To estimate serum intact parathormone(iPTH) and other biochemical parameters (calcium, inorganic phosphate, urea and creatinine) in chronic renal failure and healthy volunteers. 2. To compare and find out correlation between serum intact parathormone and biochemical parameters in the study group. Methods: For the study of 5 stages of chronic renal failure(CRF) totally 150 patients( 30 patients in each stage of CRF and 30 healthy controls) in the age group of 20-60 years were taken. Serum intact parathormone was estimated by chemilumino-metric assay and other biochemical parameters were estimated using standard methods. Creatinine clearance was calculated by using Cockcroft and Gault equation. Results: The serum iPTH (331.68 ± 204.99 pg/ml) was significantly higher in more advanced renal failure(CRF stage 5) which confirms the relationship between severity of hyperparathyroidism and the degree of renal impairment. The increased levels of serum iPTH (156.94 ± 44.26 pg/ml for CRF stage 2) were present even in early renal failure and it was related to low serum calcium level (8.46 ± 1.21 mg/dl for CRF stage 2) and progressive rise of serum inorganic phosphate from early to advanced renal failure. Therefore serum iPTH is negatively correlated with creatinine clearance(r = -0.718, p<0.001) and serum total calcium(r = -0.454, p<0.001). However, the serum iPTH is positively correlated with inorganic phosphate(r = +0.621, p<0.001), urea(r = +0.526, p<0.001) and creatinine. (r = +0.656, p<0.001). Conclusion: The estimation of serum iPTH and other biochemical parameters can help to diagnose the secondary hyperparathyroidism in the early stage of CRF which inturn has advantage to manage the patients of CRF accordingly to prevent the future complications.
منابع مشابه
Sagliker Syndrome in a Patient with Secondary Hyperparathyroidism and Chronic Renal Insufficiency: A Case Report
Sagliker syndrome is a rare form of renal osteodystrophy resulted from untreated secondary hyperparathyroidism. It is described by severe skeletal deformities, high level of PTH in patients with chronic renal failure, and deformed face. This paper reports a 44-year-old male patient with the mentioned characteristics. In addition to the unique clinical features, high levels of ALP and PTH hormon...
متن کاملManagement of chronic kidney disease: what is the evidence?
Chronic kidney disease (CKD) is a strong risk factor for cardiovascular events and death. Hypertension, dyslipidemia, anemia, vascular calcification, and secondary hyperparathyroidism have all been implicated in the pathogenesis of cardiovascular disease associated with CKD. Numerous trials have been performed assessing the effects of modifying these risk factors on cardiovascular events and on...
متن کاملInternational Burden of Chronic Kidney Disease and Secondary Hyperparathyroidism: A Systematic Review of the Literature and Available Data
The international burden of secondary hyperparathyroidism (SHPT) is unknown, but it may be estimable through the available chronic kidney disease and SHPT literature. Structured reviews of biomedical literature and online data systems were performed for selected countries to ascertain recent estimates of the incidence, prevalence, and survival of individuals with CKD and SHPT. International soc...
متن کاملObesity is associated with secondary hyperparathyroidism in men with moderate and severe chronic kidney disease.
BACKGROUND AND OBJECTIVES Obesity is associated with secondary hyperparathyroidism in the general population. The objective of this study is to explore whether the same association is present in patients with chronic kidney disease. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS Linear regression models were used to examine the association between intact parathyroid hormone level and body mass ...
متن کاملComparison of efficacy and safety of Cinacalcet versus Calcitriol in patients of secondary hyperparathyroidism in Indian population
Treatment of secondary hyperparathyroidism with vitamin-D and calcium in patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia, which may contribute to cardiovascular disease and adverse clinical outcomes. Calcimimetic agents (Cinacalcet) act on the calciumsensing receptor and lower parathyroid hormone (PTH) levels without increasing calcium and phosphorus leve...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014